Go to the profile of Exicure


  • +1 847 673 1700
  • Networkers
  • United States of America

About Exicure

Exicure is a clinical stage biotechnology company developing a new class of immunomodulatory and gene silencing drugs against validated targets. Its 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Its lead programs address diseases from inflammatory disorders to oncology.

Therapeutic Areas

Dermatology Oncology


Nucleic acids

Company Type

Biotechnology – Therapeutics

State of Ownership


Influencer Of


Editions participated in:

November 2016 September 2016